Brain Burdens of Aluminum, Iron, and Copper and their Relationships with Amyloid-β Pathology in 60 Human Brains
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The deposition in the brain of amyloid-β as beta sheet conformers associated with senile plaques and vasculature is frequently observed in Alzheimer’s disease. While metals, primarily aluminum, iron, zinc, and copper, have been implicated in amyloid-β deposition in vivo, there are few data specifically relating brain metal burden with extent of amyloid pathologies in human brains. Herein brain tissue content of aluminum, iron, and copper are compared with burdens of amyloid-β, as senile plaques and as congophilic amyloid angiopathy, in 60 aged human brains. Significant observations were strong negative correlations between brain copper burden and the degree of severity of both senile plaque and congophilic amyloid angiopathy pathologies with the relationship with the former reaching statistical significance. While we did not have access to the dementia status of the majority of the 60 brain donors, this knowledge for just 4 donors allowed us to speculate that diagnosis of dementia might be predicted by a combination of amyloid pathology and a ratio of the brain burden of copper to the brain burden of aluminum. Taking into account only those donor brains with either senile plaque scores ≥4 and/or congophilic amyloid angiopathy scores ≥12, a Cu:Al ratio of <20 would predict that at least 39 of the 60 donors would have been diagnosed as suffering from dementia. Future research should test the hypothesis that, in individuals with moderate to severe amyloid pathology, low brain copper is a predisposition to developing dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In plaques from persons with Alzheimer’s disease, iron and aluminum appear to cause plaque formation while copper and zinc may be protective [26,27,28,35,36,37].”
From The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline (2017) · cites this paper as [27]
Citations
Cites
The prevalence of dementia: A quantitative integration of the literature
Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,296
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Vinters, H. V., & Gilbert, J. J. (1983) · Stroke · doi:10.1161/01.str.14.6.924 · Cited by 504
Copper in the brain and Alzheimer’s disease
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 498
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Self-citationOlichney, J. M., Hansen, L. A., Hofstetter, C. R., Grundman, M., Katzman, R., & Thal, L. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 246
Yamaguchi, H., Yamazaki, T., Lemere, C. A., Frosch, M. P., & Selkoe, D. J. (1992) · PubMed · Cited by 216
BORCHARDT, T., CAMAKARIS, J., CAPPAI, R., MASTERS, C. L., BEYREUTHER, K., & MULTHAUP, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 171
Ikeda, S., Allsop, D., & Glenner, G. G. (1989) · PubMed · Cited by 156
Exley, C., & House, E. R. (2011) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-010-0417-y · Cited by 131
Self-citationExley, C. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.086553 · Cited by 129
Self-citationHouse, E., Esiri, M., Forster, G., Ince, P. G., & Exley, C. (2012) · Metallomics · doi:10.1039/c1mt00139f · Cited by 122
Self-citationAlafuzoff, I., Pikkarainen, M., Al-Sarraj, S., Arzberger, T., Bell, J., Bodi, I., Bogdanovic, N., Budka, H., Bugiani, O., Ferrer, I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229986.17548.27 · Cited by 117 · cited 1×
“Age of donor was positively and significantly ( = 0.05) correlated both ( r = 0.302; p = 0.019).”
InfluentialExley, C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-305 · Cited by 107
Self-citationEffect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease
Schrag, M., Crofton, A., Zabel, M., Jiffry, A., Kirsch, D., Dickson, A., Mao, X. W., Vinters, H. V., Domaille, D. W., Chang, C. J., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101503 · Cited by 79
Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease
Exley, C., Korchazhkina, O., Job, D., Strekopytov, S., Polwart, A., & Crome, P. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10103 · Cited by 61
Self-citationIron, copper and their proteins in substantia nigra of human brain during aging
Zecca, L., Zucca, F. A., Toscani, M., Adorni, F., Giaveri, G., Rizzio, E., & Gallorini, M. (2005) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-005-0650-8 · Cited by 19
Spherulites in Human Brain Tissue are Composed of Beta Sheets of Amyloid and Resemble Senile Plaques
House, E. R., Jones, K. L., & Exley, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110071 · Cited by 18
Self-citation
Cited by
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
“Iron can directly promote amyloid-b aggregation (House et al., 2004; Schubert and Chevion, 1995) and iron levels can modulate amyloid precursor protein pathways (Exley et al., 2012; Silvestri and Camaschella, 2008).”
Willhite, C. C., Karyakina, N. A., Yokel, R. A., Yenugadhati, N., Wisniewski, T. M., Arnold, I. M. F., Momoli, F., & Krewski, D. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.934439 · Cited by 412
“Controversy over what constitutes “safe” Al exposure began at least 100 years ago (Gies 1911) and questions persist concerning the role of Al in AD (Campdelacreu 2012, Exley et al. 2012, Tomljenovic 2011, Solfrizzi et al. 2011, Walton 2012a) and other disease states (AFSSAPS 2011).”
BackgroundResultThe essential elements of Alzheimer’s disease
Lei, P., Ayton, S., & Bush, A. I. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.008207 · Cited by 327
Bondy, S. C. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.002 · Cited by 263
“However, AD is also associated with other metal imbalances such as major depression of copper levels and the issue of causality remains elusive (Akatsu et al., 2012; Exley et al., 2012).”
Aluminium in brain tissue in familial Alzheimer’s disease
Mirza, A., King, A., Troakes, C., & Exley, C. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.12.001 · Cited by 261
Self-citation
Metadata
- Authors
- Exley, C., House, E., Polwart, A., & Esiri, M. M.
- Affiliations
- Keele University (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Exley, Christopher
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-09-11
- Volume
- 31
- Issue
- 4
- Pages
- 725-730
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1880679495
- Cited by
- 59
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 3
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Chinese Academy of Agricultural Sciences
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta, amyloid plaques
- MeSH terms
- Aged, Aged, 80 and over, Aluminum, Alzheimer Disease, Body Burden, Brain, Brain Chemistry, Copper, Dementia, Female, Humans, Iron, Male, Biomarkers, Amyloid beta-Peptides, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.